Ratings
Positive
Kyverna Therapeutics GAAP EPS of -$0.97 beats by $0.07
Breaking news from global financial markets
2 months ago
Read More
2 months ago
1,311
2 months ago
3,938
2 months ago
1,927
2 months ago
1,706
HGV Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
Ratings
2 months ago
1,635
2 months ago
500
2 months ago
2,408
2 months ago
3,074
2 months ago
1,448
2 months ago
3,801
2 months ago
3,356
2 months ago
2,135
2 months ago
2,046
2 months ago
4,193
2 months ago
3,455
2 months ago
649
2 months ago
4,744
Boston Scientific At The Starting Line Again After Its Stock Hits A Record High, Consolidates.
Ratings
2 months ago
2,887
Trending Now
1
Businesses' use of AI comes with plenty of stops and starts
13,618
47 minutes ago
2
'We're At This Intermediate Stage': Ex-Tesla AI Chief Andrej Karpathy Says AGI I...
47,859
57 minutes ago
3
TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NA...
29,031
58 minutes ago
4
AI’s Bright Line Bottlenecks: 3 Stocks Poised to Break Through to Massive Growth
31,371
59 minutes ago
5